Trial
NCT04318444
Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Columbia University
Collaborators
—
Condition
COVID-19
Intervention
Hydroxychloroquine
Why stopped
The Institutional Review Board closed the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-25